Clearside Biomedical Inc. | Key People and Executives
Daniel H. White
President, Chief Executive Officer & Director
William D. Humphries
Chairman
Christy L. Shaffer
Independent Director
George M. Lasezkay
Independent Director
Richard J. Croarkin
Independent Director
Evgeny V. Zaytsev
Independent Director
Clay Bernardin Thorp
Independent Director
Daniel H. White
President, Chief Executive Officer & Director
Charles A. Deignan
Secretary, Chief Financial & Accounting Officer
Carol Hoang
Vice President-Medical Affairs
Glenn Noronha
Chief Scientific Officer
Brion Raymond
Chief Commercial Officer
Rick McElheny
Vice President-Business Development
Jennifer M. Kissner
Vice President-Clinical Development
Rafael V. Andino
Vice President-Engineering & Manufacturing
Stephen Kilmer
Investor Relations
William D. Humphries
Chairman
Christy L. Shaffer
Independent Director
George M. Lasezkay
Independent Director
Richard J. Croarkin
Independent Director
Evgeny V. Zaytsev
Independent Director
Clay Bernardin Thorp
Independent Director
| Address |
900 North Point parkway
Alpharetta Georgia 30005
United States
|
|
Employees
|
- |
| Website |
http://www.clearsidebio.com |
| Updated |
07/08/2019 |
| Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. |
